Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey. by Homfray, Virginia et al.
Homfray, V; Tanton, C; Miller, RF; Beddows, S; Field, N; Sonnen-
berg, P; Wellings, K; Panwar, K; Johnson, AM; Mercer, CH (2015)
Male Circumcision and STI Acquisition in Britain: Evidence from a
National Probability Sample Survey. PLoS One, 10 (6). e0130396.
ISSN 1932-6203 DOI: 10.1371/journal.pone.0130396
Downloaded from: http://researchonline.lshtm.ac.uk/2212608/
DOI: 10.1371/journal.pone.0130396
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE
Male Circumcision and STI Acquisition in
Britain: Evidence from a National Probability
Sample Survey
Virginia Homfray1, Clare Tanton1, Robert F. Miller1, Simon Beddows2, Nigel Field1,
Pam Sonnenberg1, KayeWellings3, Kavita Panwar2, Anne M. Johnson1, Catherine
H. Mercer1*
1 Research Department of Infection and Population Health, University College London, London, United
Kingdom, 2 Virus Reference Department, Public Health England, London, United Kingdom, 3 Centre for
Sexual and Reproductive Health Research, London School of Hygiene and Tropical Medicine, London,
United Kingdom
* c.mercer@ucl.ac.uk
Abstract
Background
It is well-established that male circumcision reduces acquisition of HIV, herpes simplex
virus 2, chancroid, and syphilis. However, the effect on the acquisition of non-ulcerative sex-
ually transmitted infections (STIs) remains unclear. We examined the relationship between
circumcision and biological measures of three STIs: human papillomavirus (HPV), Chla-
mydia trachomatis andMycoplasma genitalium.
Methods
A probability sample survey of 15,162 men and women aged 16-74 years (including 4,060
men aged 16-44 years) was carried out in Britain between 2010 and 2012. Participants
completed a computer-assisted personal interview, including a computer-assisted self-
interview, which asked about experience of STI diagnoses, and circumcision. Additionally,
1,850 urine samples from sexually-experienced men aged 16-44 years were collected and
tested for STIs. Multivariable logistic regression was used to calculate adjusted odds ratios
(AOR) to quantify associations between circumcision and i) self-reporting any STI diagnosis
and ii) presence of STIs in urine, in men aged 16-44 years, adjusting for key socio-demo-
graphic and sexual behavioural factors.
Results
The prevalence of circumcision in sexually-experienced men aged 16-44 years was 17.4%
(95%CI 16.0-19.0). There was no association between circumcision and reporting any pre-
vious STI diagnoses, and specifically previous chlamydia or genital warts. However, circum-
cised men were less likely to have any HPV type (AOR 0.26, 95% confidence interval (CI)
0.13-0.50) including high-risk HPV types (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59
and/or 68) (AOR 0.14, 95% CI 0.05-0.40) detected in urine.
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Conclusions
Circumcised men had reduced odds of HPV detection in urine. These findings have implica-
tions for improving the precision of models of STI transmission in populations with different
circumcision prevalence and in designing interventions to reduce STI acquisition.
Introduction
It is well-established that male circumcision reduces HIV acquisition.[1–3] A meta-analysis
concluded that male circumcision is also associated with a lower risk of infection with herpes
simplex virus type 2, chancroid and syphilis.[4] However, the effect of male circumcision on
non-ulcerative sexually transmitted infections (STIs) remains unclear.
Human Papillomavirus (HPV) is highly prevalent.[5] Persistent infection with ‘high-risk’
types (HR-HPV) is essential for the development of cervical cancer in women, and anal cancer
in both men and women. HR-HPV has also been associated with penile cancers in men.[6]
‘Possible HR-HPV’ types are those with no clear evidence of carcinogenicity in humans, and
types HPV-6 and HPV-11 are responsible for around 85% of genital warts.[7] A meta-analysis
using detection of HPV DNA and/or genital warts (by self-report/clinical examination) as out-
comes found that circumcision was strongly protective against HPV DNA detection (summary
odds ratio (OR) 0.57; 95% Confidence Interval (CI) 0.45–0.71), but with substantial between-
study heterogeneity, which may partly reflect the fact that most of the data were from conve-
nience samples with relatively small sample sizes, while circumcision did not afford protection
against genital warts.[8]
Chlamydia trachomatis andMycoplasma genitalium are bacterial STIs possibly associated
with upper reproductive tract infection in women. A randomised trial of circumcision to pre-
vent acquisition of HIV in Kenya found Chlamydia infection was reduced in the intervention
arm, but this lacked significance (incidence rate ratio 0.87, 95% CI 0.65–1.16).[9] However, in
the same trial, circumcision almost halved the odds of detectingM. genitalium (OR 0.54; 95%
CI 0.29–0.99), after controlling for behavioural risks.[9] A similar trial in South Africa demon-
strated a decrease in prevalence of C. trachomatis in circumcised participants (adjusted OR
0.56; 95% CI 0.32–1.00).[10] However, few other studies have investigated the association
between circumcision and these pathogens.
Our study examined the relationship between male circumcision and reporting previous
STI diagnoses or detecting HPV, C. trachomatis andM. genitalium in urine among men in the
British general population.
Materials and Methods
The third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) was a stratified proba-
bility sample survey of 15,162 men and women (6293 men) aged 16–74 years in Britain, who
were interviewed during 2010–2012. The overall response rate was 57.7%. Participants were
interviewed using computer-assisted face-to-face and self-interviews (CASI). The CASI
included questions about male circumcision, sexual behaviour and history of STI diagnoses.
Further methodological details have been described elsewhere.[11,12]
After the interview, a sample of participants aged 16–44 years who reported at least one life-
time sexual partner were invited to provide urine for STI testing.[5,11] Samples were tested for
HPV, C. trachomatis andM. genitalium. STI test results were available from 1,850 men. HPV
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types were classified as high-risk, possible high-risk or HPV-6/11 using the IARC Monograph
Working Group classification [13] (see Table 2). Details of the urine collection methods and
testing procedures are published elsewhere.[5] Briefly, detection of C. trachomatis used the
Aptima Combo 2 assay (Hologic Gen-Probe) as the initial screen and all positive or equivocal
results were confirmed with the Aptima monospecific assay. An in-house Luminex-based gen-
otyping assay was used to detect HPV types.[14]M. genitalium detection used an in-house
Real-Time PCR assay which targets the adhesin protein (MgPa) gene, [15] with positive or
equivocal results confirmed using a Genprobe Mycoplasma test. [16]
Stata (version 12.1) was used for all statistical analyses accounting for the stratification, clus-
tering, and weighting of the sample, which was broadly representative of the British popula-
tion.[11] Analyses were additionally weighted for unequal urine selection probabilities and
differential urine sample response.[11] The denominator was limited to men aged 16–44 years
reporting one or more lifetime partner. Prevalence estimates of self-reported circumcision with
95% confidence intervals (CIs) are presented. Associations between circumcision and demo-
graphic and behavioural variables were examined using logistic regression to calculate odds
ratios (ORs). Crude and age-adjusted ORs are presented. To examine the association between
circumcision and self-reported STI diagnoses or biological outcomes multivariable analysis
was used to calculate ORs adjusted for age, ethnicity, same-sex experience and either number
of lifetime partners (for STI diagnosis outcomes) or number of partners without a condom in
the past year (for biological outcomes) (adjusted OR [AOR]).
All participants were given an information leaflet to read prior to participating in the survey
and had the opportunity to discuss this with the interviewer. Verbal informed consent was
obtained for participation in the interview and interviewers had to confirm that respondents
had read the information leaflet in the computer programme before commencing the inter-
view. Participants gave written informed consent for anonymised testing of urine samples,
without the return of results, the ethical rationale for which has been previously described.[14]
The Natsal-3 study, including the consent procedures, was approved by the Oxfordshire
Research Ethics Committee A (reference: 09/H0604/27). All participants provided their own
consent to participate, however for 16–17 year olds living at home, a parent/guardian provided
additional verbal assent for participation. At the time of writing, the Natsal-3 data are being
prepared for archiving with the UK Data Archive in June 2015, but before then, researchers
may contact the Natsal-3 team to seek advance access to the corresponding data, and are
directed to the Natsal website for further information (www.natsal.ac.uk).
Results
The prevalence of reported circumcision in sexually-experienced men aged 16–44 resident in
Britain was 17.4% (95% CI 16.0–19.0). Prevalence increased with age, from 13.2% (95% CI
11.3–15.5) among men aged 16–24 to 18.4% (95% CI 15.5–21.6) among men aged 35–44
(Table 1). Prevalence of male circumcision varied greatly according to ethnicity and religion,
with men from ethnic minority backgrounds being significantly more likely to report being cir-
cumcised than men of White ethnicity. In unadjusted analyses, the odds of circumcision were
45.01 (95%CI 24.26–83.51) times higher in Muslim men than in those of no religious back-
ground. This association remained after adjusting for age. There were no associations between
circumcision and the key sexual behaviours studied.
Circumcision was not associated with reporting previous diagnosis/es of any STI, or specifi-
cally chlamydia or genital warts in 16–44 year old men (Table 2). Results were similar in 16–74
year old men (data not shown). In unadjusted analyses, any HPV type was less likely to be
detected in circumcised men as were HR-HPV and possible HR-HPV types (but not HPV
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Table 1. Variations in the prevalence of circumcision by key sociodemographic factors and sexual behaviours reported by sexually–experienced1
men aged 16–44 years in Britain’s third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).
Circumcised OR (95%CI) p-value Age-
adjusted OR
(95%CI) Denom.
(unwt, wt)1
% (95%CI)
All
Sociodemographics
Age (years) p = 0.0005
16–24 13.20% (11.3–
15.5)
1 - 1343, 979
25–34 19.60% (17.5–
22.0)
1.6 (1.26–
2.03)
1425, 1273
35–44 18.40% (15.5–
21.6)
1.47 (1.12–
1.94)
777, 1374
Relationship status p = 0.0324 p = 0.2641
Living with partner 19.10% (17.0–
21.5)
1 - 1 - 1603, 2130
Steady relationship, not cohabiting 13.80% (11.0–
17.2)
0.68 (0.50–
0.91)
0.75 (0.54–
1.05)
769, 586
No steady relationship, previously
cohabited
15.60% (11.7–
20.6)
0.78 (0.54–
1.13)
0.8 (0.55–
1.15)
338, 272
No steady relationship, never
cohabited
15.50% (12.8–
18.7)
0.78 (0.59–
1.02)
0.88 (0.64–
1.21)
821, 627
Academic qualiﬁcations 2 p = 0.0012 p = 0.0003
No academic qualiﬁcations 16.60% (12.0–
22.6)
1 - 1 - 316, 347
Academic qualiﬁcations typically
gained at age 16
13.60% (11.5–
16.1)
0.79 (0.51–
1.21)
0.81 (0.53–
1.25)
1216, 1248
Studying for/attained further
academic qualiﬁcations
19.80% (17.7–
22.1)
1.24 (0.83–
1.86)
1.35 (0.90–
2.04)
1815, 1860
Ethnic group p<0.0001 p<0.0001
White 12.00% (10.8–
13.4)
1 - 1 - 3106, 3093
Mixed 37.40% (26.1–
50.3)
4.38 (2.58–
7.45)
4.63 (2.72–
7.88)
88, 82
Asian/Asian British 48.80% (40.0–
57.6)
6.97 (4.80–
10.13)
6.83 (4.67–
9.97)
175, 254
Black/Black British 64.40% (53.9–
73.8)
13.26 (8.38–
20.99)
13.27 (8.37–
21.02)
123, 137
Other 29.80% (17.0–
46.8)
3.10 (1.50–
6.43)
3.15 (1.50–
6.64)
47, 53
Religion p<0.0001 p<0.0001
None 13.60% (12.0–
15.4)
1 - 1 - 2288, 2249
Christian 16.20% (13.6–
19.3)
1.23 (0.96–
1.58)
1.2 (0.93–
1.55)
1022, 1091
Muslim 87.60% (79.5–
92.8)
45.01 (24.26–
83.51)
45.44 (24.62–
83.86)
119, 149
Hindu 3.90% (1.2–
11.7)
0.26 (0.08–
0.83)
0.24 (0.07–
0.79)
45, 69
Other 21.50% (13.3–
32.9)
1.74 (0.96–
3.16)
1.8 (0.98–
3.27)
66, 63
Sexual behaviours
Number of sexual partners 3 over the lifetime p = 0.256 p = 0.1224
(Continued)
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types 6 and 11; Table 2). Circumcised men were also less likely to have C. trachomatis, but not
M. genitalium detected (Table 2). After adjusting for key demographic and behavioural vari-
ables (Table 2), circumcised men were still less likely to have any HPV-type detected in their
urine when compared with uncircumcised men (AOR 0.26, 95% CI 0.13–0.50). An association
also remained for both HR-HPV (AOR 0.14, 95% CI 0.05–0.40) and possible HR-HPV (AOR
0.24, 95% CI 0.06–0.94) and for C. trachomatis (AOR 0.09, 95% CI 0.01–0.77). Unadjusted and
adjusted ORs for the association between circumcision andM. genitalium differed substantially
due to confounding by ethnicity.
Table 1. (Continued)
Circumcised OR (95%CI) p-value Age-
adjusted OR
(95%CI) Denom.
(unwt, wt)1
% (95%CI)
1 21.00% (16.8–
25.9)
1 - 1 - 483, 490
2 20.50% (15.1–
27.0)
0.97 (0.62–
1.53)
0.99 (0.63–
1.56)
306, 303
3–4 17.40% (13.9–
21.6)
0.8 (0.55–
1.15)
0.79 (0.55–
1.14)
532, 528
5–9 16.00% (13.1–
19.2)
0.72 (0.50–
1.02)
0.68 (0.48–
0.97)
865, 900
10+ 16.40% (14.3–
18.7)
0.74 (0.53–
1.02)
0.69 (0.49–
0.96)
1316, 1361
Same sex experience, ever 4 p = 0.8434 p = 0.8289
No 17.40% (15.9–
19.0)
1 - 1 - 3343, 3436
Yes 18.00% (12.7–
25.0)
1.04 (0.68–
1.60)
1.05 (0.68–
1.61)
202, 189
Number of sexual partners 3, past year p = 0.723 p = 0.7831
0 17.80% (12.2–
25.3)
1 - 1 - 189, 172
1 17.70% (15.8–
19.7)
0.99 (0.62–
1.58)
0.98 (0.61–
1.56)
2294, 2581
2 14.50% (11.0–
18.8)
0.78 (0.46–
1.35)
0.84 (0.49–
1.47)
421, 355
3–4 18.20% (13.7–
23.7)
1.03 (0.59–
1.79)
1.1 (0.63–
1.93)
354, 287
5+ 17.80% (12.9–
24.1)
1 (0.55–
1.81)
1.1 (0.60–
2.01)
251, 193
Number of sexual partners 3 without a condom, past year p = 0.6247 p = 0.9503
0 16.50% (13.6–
20.0)
1 - 1 - 859, 781
1 17.80% (15.8–
19.9)
1.09 (0.83–
1.43)
1.03 (0.78–
1.35)
2104, 2372
2+ 15.80% (12.4–
20.0)
0.95 (0.65–
1.38)
0.98 (0.67–
1.41)
513, 410
1 Unweighted, weighted denominators: all 16–44 year old men reporting at least one lifetime partner by the time of their interview for Natsal-3
2 Participants aged 17 years
3 Includes both opposite and same-sex partners
4 Same-sex experience involving genital contact
doi:10.1371/journal.pone.0130396.t001
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Discussion
Findings from this large British population-based survey show that male circumcision is
strongly associated with lower detection of any HPV and HR-HPV in urine, even after adjust-
ing for key demographic and behavioural variables. However, circumcision was not associated
with self-reported previous STI diagnosis/es in this population.
The strengths of this study are that the initial Natsal-3 sample size is large, and probability
sampling gives data representative of the British general population.[11] In contrast, studies
included in the meta-analysis of the association between HPV and genital warts and circumci-
sion were generally convenience samples with relatively small sample sizes.[8] In addition to
using self-reports of STI diagnosis/es, which may be subject to reporting bias (despite using
CASI to collect these data [11]), Natsal-3 used biological markers of STI, which have greater
reliability.[17] However, as the population prevalence of some of the STIs considered was low
(specifically HPV-6/11, C. trachomatis andM. genitalium),[5] statistical power was too low to
detect modest differences in prevalence. Thus, the observed strong association between circum-
cision and lower detection of Chlamydia should be interpreted with caution since the 95%CIs
around this are wide. It is also necessary to consider the method of sample collection. Urine
tests for C. trachomatis andM. genitalium are regarded as the ‘gold standard’ in men, but urine
is considered a suboptimum specimen for detection of HPV. Hernandez et al assessed HPV
prevalence at different sites and found that it was highest in the penile shaft (52% at this site)
compared to just 10% in urine,[18] suggesting that HPV prevalence may be underestimated in
our study. Another study found no difference in prevalence of HR-HPV in urethral swabs
when comparing swabs taken before and after circumcision.[19] Although detection bias
Table 2. Variations in the reported diagnosis of, and detection of, current infection, of key STIs among sexually-experiencedmen aged 16–44
years in Britain’s third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).
Circumcised men Uncircumcised men
% (95%CI) % (95%CI) OR (95%CI) AOR1 (95%CI)
Reported diagnosis of:
Denom. (unwt, wt) 2 561, 627 2969, 2980
Any STI 3 13.7% (10.8–17.2) 13.9% (12.4–15.5) 0.98 (0.73–1.32) 1.05 (0.75–1.48)
Chlamydia infection 6.5% (4.8–8.8) 6.2% (5.3–7.2) 1.06 (0.73–1.52) 1.23 (0.81–1.86)
Genital warts 3.5% (2.2–5.6) 3.9% (3.1–4.9) 0.88 (0.51–1.51) 1.05 (0.60–1.86)
Current infection with:
Denom. (unwt, wt) 4 284, 403 1566, 1821
HPV (any) 6.4% (4.0–10.2) 18.6% (16.1–21.3) 0.30 (0.18–0.51) 0.26 (0.13–0.50)
HR-HPV 5 2.3% (1.0–4.9) 9.8% (7.8–12.2) 0.21 (0.09–0.49) 0.14 (0.05–0.40)
Possible HR-HPV 6 0.6% (0.2–2.0) 2.4% (1.6–3.7) 0.25 (0.07–0.86) 0.24 (0.06–0.94)
HPV-6/11 0.7% (0.2–2.5) 1.5% (0.8–2.7) 0.48 (0.11–2.00) 0.58 (0.16–2.10)
Chlamydia trachomatis 0.1% (0.0–0.7) 1.3% (0.9–1.9) 0.08 (0.01–0.59) 0.09 (0.01–0.77)
Mycoplasma genitalium 1.9% (0.7–5.1) 1.0% (0.6–1.7) 1.90 (0.62–5.87) 0.61 (0.18–2.09)
1 ORs adjusted for age, ethnicity, same sex experience and number of partners in lifetime (for diagnosis outcomes) or number of partners without a
condom in the past year (for biological outcomes)
2 Unweighted, weighted denominators: all 16–44 year old men reporting at least one lifetime partner by the time of their interview for Natsal-3
3 Deﬁned as chlamydia, gonorrhoea, genital warts, syphilis, trichomonas, herpes, NSU/NGU, epididymo-orchitis, public lice/crabs or hepatitis
4 Unweighted, weighted denominators: 16–44 year old men with one or more lifetime partner who provided a urine sample
5 Positive for type(s) 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68
6 Positive for type(s) 26, 53, 66, 70, 73 and/or 82
doi:10.1371/journal.pone.0130396.t002
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remains a possible explanation for our findings if the presence of the foreskin means that urine
may collect HPV coming from other sites (e.g. the glans/corona,[18,20,21] where prevalence is
higher), in addition to the urethra. However, a systematic review and meta-analysis, which
included data collected from a variety of anatomical sites, found results similar to our study
and a stronger effect of circumcision at sites more proximal to the foreskin (urethra and glans/
corona)[8] suggesting that the results presented here may not solely be due to differential
detection.
The lack of association between male circumcision and self-reported previous STI diagnoses
is in keeping with Natsal-2 findings,[22] and the meta-analysis of the association between cir-
cumcision and HPV,[8] which reported significantly lower odds of any HPV type (at any ana-
tomical site) in circumcised men compared to uncircumcised men but no association with
genital warts. Our data suggest an association between circumcision and lower odds of detec-
tion of C. trachomatis, consistent with some,[10] but not all other studies.[9] However, we did
not find an association with reported diagnosis of Chlamydia. We are unable to compare our
findings for HPV-6/11 orM. genitalium to the findings of other studies due to insufficient sta-
tistical power.
Data from a large national probability survey have shown that male circumcision is associ-
ated with lower odds of detecting oncogenic HPV types. Reduced prevalence of oncogenic
HPV types among men may result in reduced transmission to sexual partners, with the conse-
quent effect of reduced risk of cervical cancer. Castellasgue et al. observed that monogamous
women whose partners had reported six or more sexual partners and were circumcised were at
lower risk of cervical cancer than monogamous women whose partners were uncircumcised.
[23] Currently the World Health Organisation advocates male circumcision for HIV preven-
tion;[24] reduction in HPV acquisition would add to the overall health benefit resulting from
the scale-up of male circumcision in countries with high prevalence of HIV. In such settings
this reduction could be important due to the higher incidence of cervical cancer, particularly
among HIV positive women, as well as other HPV related cancers in both men and women
than in higher income countries,[25] and the low or absent HPV vaccination coverage. This
present study shows that male circumcision is associated with lower odds of detection of
HR-HPV types, meaning it may convey a long-term public health benefit. Future research
should be directed towards determining whether male circumcision might contribute to reduc-
ing rates of cervical, penile, anal and oral cancers.
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